Meeting
Abstract Number: 120
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity, mortality, and cost with the greatest proportion incurred treating acute exacerbations of COPD (AECOPD). While guidelines recommend oral steroids for the treatment of AECOPD, parental corticosteroids are still used in the inpatient setting; such use is associated with high costs and adverse effects. The […]
Abstract Number: 138
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Chronic Obstructive Pulmonary Disease (COPD) is a lung disease characterized by chronic, irreversible airway obstruction that can precipitate into acute exacerbations (AECOPD) of cough, dyspnea and sputum production, often requiring hospitalization. Hospital systems aiming to improve outcomes for patients with AECOPD are testing innovative approaches to care in the acute care setting. To enroll […]
Abstract Number: 1211
Hospital Medicine 2020, Virtual Competition
Background: Chronic Obstructive Pulmonary Disease (COPD) is among the top three leading causes of hospital readmissions in the United States. Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD) is associated with increased morbidity, mortality, and cost with AECOPD accounting for more than half of the 15.5 billion USD spent on COPD[1,2]. In this project, we aim […]